L
Laurus Labs Ltd
Pharmaceuticals
MIDCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 127.96 | 36.86 |
| PB Ratio | 9.96 | 6.12 |
| Dividend Yield | 0.14% | 0.79% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
L
Laurus Labs Ltd
Laurus Labs Private Ltd is a research and development pharmaceutical company which manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in o...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions